HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study)

NCT03500172 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1391

Last updated 2026-01-14

Study results available
· View outcomes & findings →

Summary

The Siyaphambili Study is a sequential multistage adaptive randomized trial (SMART) to compare the effectiveness and durability of two behavioral interventions on the HIV-1 virologic response among female sex workers (FSW) living with HIV in Durban, South Africa. The interventions are: 1) nurse-led decentralized treatment program (DTP) and 2) individualized case management (ICM). Viral suppression is defined as a viral load assessment \<50 RNA copies/mL. The design will also estimate the incremental cost-effectiveness of study interventions and combinations of interventions compared with maintaining the South African standard of HIV care and treatment.

Conditions

  • HIV-1 Virologic Response

Interventions

BEHAVIORAL

DTP

Provision of antiretroviral therapy (ART) in the community through a mobile-van DTP managed by a nurse capable of initiating and managing ART.

BEHAVIORAL

ICM

Peer-led ICM through quarterly face-to-face meetings, monthly phone calls and biweekly text messages.

Sponsors & Collaborators

  • University of the Western Cape

    collaborator OTHER
  • TB HIV Care

    collaborator OTHER
  • University of Toronto

    collaborator OTHER
  • University of California, San Francisco

    collaborator OTHER
  • National Institute for Communicable Diseases, South Africa

    collaborator OTHER
  • Johns Hopkins Bloomberg School of Public Health

    lead OTHER

Principal Investigators

  • Stefan Baral, MD, MPH · Johns Hopkins Bloomberg School of Public Health

  • Harry Hausler, MD, MPH · TB HIV Care

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-22
Primary Completion
2021-11-24
Completion
2022-01-05

Countries

  • South Africa

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03500172 on ClinicalTrials.gov